Lenox Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$1.63M Sell
17,713
-1,320
-7% -$127K 0.5% 36
2020
Q1
$1.73M Buy
19,033
+1,014
+6% +$108K 0.59% 32
2019
Q4
$2.05M Sell
18,019
-768
-4% -$84.3K 0.58% 36
2019
Q3
$2.05M Sell
18,787
-160
-0.8% -$16.7K 0.6% 36
2019
Q2
$1.84M Buy
18,947
+338
+2% +$30.9K 0.55% 38
2019
Q1
$1.7M Buy
18,609
+216
+1% +$19.3K 0.53% 40
2018
Q4
$1.68M Sell
18,393
-615
-3% -$57.5K 0.57% 41
2018
Q3
$1.88M Buy
19,008
+2,049
+12% +$189K 0.56% 40
2018
Q2
$1.45M Buy
16,959
+260
+2% +$21.7K 0.47% 40
2018
Q1
$1.35M Buy
16,699
+385
+2% +$31.8K 0.43% 53
2017
Q4
$1.32M Buy
16,314
+3,163
+24% +$253K 0.4% 51
2017
Q3
$1.03M Buy
13,151
+2,583
+24% +$214K 0.35% 52
2017
Q2
$938K Buy
+10,568
New +$891K 0.38% 51

Other funds holding MDT

Lenox Wealth Management's MDT Position: Q2 2020 in Review

Lenox Wealth Management reduced its Medtronic (MDT) stake by 6.9% in Q2 2020, selling an estimated $127K and leaving 17,713 shares worth $1.63M. The position accounts for 0.5% of the portfolio, ranked #36.

Lenox Wealth Management first reported a position in MDT in Q2 2017 and has held it in 13 quarters since. The position peaked at $2.05M in Q4 2019. 1,759 funds tracked by Wall St. Rank hold MDT as of Q2 2020.

  • Lenox Wealth Management held 17,713 shares of Medtronic worth $1.63M as of Q2 2020.
  • Lenox Wealth Management sold 1,320 Medtronic shares in Q2 2020, an estimated $127K.
  • Medtronic made up 0.5% of Lenox Wealth Management's portfolio in Q2 2020, its #36 holding.
  • Lenox Wealth Management first reported a position in Medtronic in Q2 2017 and has held it in 13 quarters since.
  • Lenox Wealth Management's Medtronic position peaked at $2.05M in Q4 2019.
  • 1,759 funds tracked by Wall St. Rank held Medtronic as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.